Dementia & Alzheimer’s Disease Clinical Trials
Burke Rehabilitation Hospital is a leader in rehabilitation medicine and continues to make strides through its cutting-edge clinical research. Burke conducts clinical trials in a number of areas, including dementia and Alzheimer's disease research. These clinical trials can hopefully slow cognitive decline and/or treat associated symptoms. Patients are encouraged to learn more about the trials offered at Burke and inquire about whether they meet the inclusive and exclusion criteria specific to the study. Patients, as well as their physicians or family members can call to find out more.
Burke is conducting a clinical trial to evaluate whether increasing brain glucose utilization can slow cognitive decline in individuals with Mild Cognitive Impairment or mild Alzheimer's disease dementia. Click here for more information on the trial.
Currently, there are three clinical trials for dementia and Alzheimer's disease research underway at Burke. Click on the below links to learn more about each trial.
- Benfotiamine trial for individuals with mild cognitive impairment or mild Alzheimer's disease dementia
- TRIAD research study for individuals with mild to severe agitation due to Alzheimer's disease
- Cognite Trial for individuals with early signs of memory loss or mild Alzheimer's disease
For more information about each trial and to find out if you or your family member qualify, contact Rosanna Cirio at (914) 597-2476 or email@example.com.
*Compensation may be available, depending on the study.
Vitamin B1 and Dementia
Dr. Gary Gibson joins Wall Street Journal’s Lunch Break with Tanya Rivero to talk about the link between of Vitamin B1 and Alzheimer’s or other forms of dementia.
Learn about Enrolling in this Alzheimer's and Dementia Trials
If you would like more information regarding current Alzheimer's and dementia trials, please contact: Rosanna Cirio, MA at